Literature DB >> 15758415

Bone mineral density in beta - thalassemic Lebanese children.

A Yazigi1, G Maalouf, A Inati-Khoriati, H Tamim, C Saab.   

Abstract

Osteoporosis has been described extensively in adult thalassemics. Fewer studies have been reported in thalassemic children. In this article, we measured the bone mineral density (BMD) of Lebanese beta-thalassemic children before institution of a balanced transfusion-chelation regimen, in comparison with that of healthy controls, and studied its correlation with various demographic and biological parameters. Both groups, controls and thalassemics were comparable with respect to age, sex, socioeconomic and regional distribution. On the other hand, thalassemics had a significantly lower height age (p<0.001), lower bone age (p=0.001), lower sexual maturation (p=0.004), lower absolute BMD values and larger negative BMD-Z scores (p<0.001). Within the thalassemic group, BMD correlated significantly with luteinizing hormone (LH) and follicle stimulating hormone (FSH), estradiol and testosterone values, as well as with the pretransfusion hematocrit, but not with other endocrine or bone metabolism parameters. We conclude that Lebanese beta-thalassemic children have a significantly lower BMD than their healthy counterparts due, in part, to their slower physical development. A major contributor seems to be the low-transfusion regimen followed by these patients, as well as the endocrine dysfunction which was detected in about 25% of them.

Entities:  

Year:  2002        PMID: 15758415

Source DB:  PubMed          Journal:  J Musculoskelet Neuronal Interact        ISSN: 1108-7161            Impact factor:   2.041


  7 in total

Review 1.  Effects of erythropoietin on the bone microenvironment.

Authors:  S J McGee; A M Havens; Y Shiozawa; Y Jung; R S Taichman
Journal:  Growth Factors       Date:  2011-11-28       Impact factor: 2.511

2.  Evaluation of osteopathy in thalassemia by bone mineral densitometry and biochemical indices.

Authors:  Rashid Merchant; Amish Udani; Vipla Puri; Valentina D'cruz; Deepak Patkar; Aarti Karkera
Journal:  Indian J Pediatr       Date:  2010-08-25       Impact factor: 1.967

3.  Endocrine and metabolic disorders in β-thalassemiamajor patients.

Authors:  Fatemeh Saffari; Abolfazl Mahyar; Shabnam Jalilolgadr
Journal:  Caspian J Intern Med       Date:  2012

4.  Erythropoietin mediated bone formation is regulated by mTOR signaling.

Authors:  Jinkoo Kim; Younghun Jung; Hongli Sun; Jeena Joseph; Anjali Mishra; Yusuke Shiozawa; Jingcheng Wang; Paul H Krebsbach; Russell S Taichman
Journal:  J Cell Biochem       Date:  2012-01       Impact factor: 4.429

5.  Erythropoietin couples hematopoiesis with bone formation.

Authors:  Yusuke Shiozawa; Younghun Jung; Anne M Ziegler; Elisabeth A Pedersen; Jianhua Wang; Zhuo Wang; Junhui Song; Jingcheng Wang; Clara H Lee; Sudha Sud; Kenneth J Pienta; Paul H Krebsbach; Russell S Taichman
Journal:  PLoS One       Date:  2010-05-27       Impact factor: 3.240

6.  Bone-related complications of transfusion-dependent beta thalassemia among children and adolescents.

Authors:  Naghmeh Zahra Mirhosseini; Suzana Shahar; Majid Ghayour-Mobarhan; Abdullah Banihashem; Nor Azmi Kamaruddin; Mohammad Reza Hatef; Habib Alah Esmaili
Journal:  J Bone Miner Metab       Date:  2013-03-10       Impact factor: 2.626

7.  Complete blood picture with skeletal and visceral changes in patients with thalassemia major.

Authors:  Ramsha Mehmood; Uzair Yaqoob; Asma Sarfaraz; Ujala Zubair
Journal:  Int J Health Sci (Qassim)       Date:  2018 Jul-Aug
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.